Prognostic importance of tumour-infiltrating memory T cells in oesophageal squamous cell carcinoma

被引:52
作者
Enomoto, K. [1 ]
Sho, M. [1 ]
Wakatsuki, K. [1 ]
Takayama, T. [1 ]
Matsumoto, S. [1 ]
Nakamura, S. [1 ]
Akahori, T. [1 ]
Tanaka, T. [1 ]
Migita, K. [1 ]
Ito, M. [1 ]
Nakajima, Y. [1 ]
机构
[1] Nara Med Univ, Dept Surg, Kashihara, Nara 6348522, Japan
关键词
CD45RO; memory cells; oesophagus; prognosis; surgery; CLINICAL-SIGNIFICANCE; GROWTH-FACTOR; EXPRESSION; CANCER; LYMPHOCYTES; MANAGEMENT; THERAPIES; ANTIGENS; SURVIVAL; RECEPTOR;
D O I
10.1111/j.1365-2249.2012.04565.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Memory T cells survive for many months and years and are critically important for host defence in humans. In tumour immunity, they have been also suggested to play a significant role in tumour progression and metastasis. However, the role of memory T cells in actual human cancer remains largely unknown. In this study, the clinical importance of tumour-infiltrating CD45RO+ memory T cells was investigated in human oesophageal squamous cell carcinoma (OSCC). CD45RO+ T cells were evaluated by immunohistochemistry in primary OSCC tumours from 105 patients. Patients were classified into two groups as CD45RO+hi or CD45RO+lo based on the number of cells stained positively for CD45RO. No significant difference was observed between CD45RO status and several clinicopathological prognostic factors. However, the postoperative overall and disease-free survival for CD45RO+hi patients was significantly better than for CD45RO+lo patients. Furthermore, there were significant correlations of CD45RO status in the primary tumour with postoperative lymph node and pulmonary recurrence, suggesting that memory T cells may control postoperative metastatic recurrence. Most importantly, CD45RO+ memory T cell status has a significant prognostic value for OSCC independently of conventional tumournodemetastasis (TNM) classification. Our study may provide a rationale for developing a novel immunotherapy in intentional induction of memory T cells for the treatment of oesophageal cancer.
引用
收藏
页码:186 / 191
页数:6
相关论文
共 35 条
[1]  
Bennett MW, 1998, J IMMUNOL, V160, P5669
[2]  
BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005
[3]   Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family [J].
Bour-Jordan, Helene ;
Esensten, Jonathan H. ;
Martinez-Llordella, Marc ;
Penaranda, Cristina ;
Stumpf, Melanie ;
Bluestone, Jeffrey A. .
IMMUNOLOGICAL REVIEWS, 2011, 241 :180-205
[4]   Clinical relevance of Fas expression in oesophageal squamous cell carcinoma [J].
Chan, KW ;
Lee, PY ;
Lam, AKY ;
Law, S ;
Wong, J ;
Srivastava, G .
JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (01) :101-104
[5]  
Cho Y, 2003, CANCER RES, V63, P1555
[6]   Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [J].
Galon, Jerom ;
Costes, Anne ;
Sanchez-Cabo, Fatima ;
Kirilovsky, Amos ;
Mlecnik, Bernhard ;
Lagorce-Pages, Christine ;
Tosolini, Marie ;
Camus, Matthieu ;
Berger, Anne ;
Wind, Philippe ;
Zinzindohoue, Franck ;
Bruneval, Patrick ;
Cugnenc, Paul-Henri ;
Trajanoski, Zlatko ;
Fridman, Wolf-Herman ;
Pages, Franck .
SCIENCE, 2006, 313 (5795) :1960-1964
[7]   The adaptive immunologic microenvironment in colorectal cancer:: A novel perspective [J].
Galon, Jerome ;
Fridman, Wolf-Herman ;
Pages, Franck .
CANCER RESEARCH, 2007, 67 (05) :1883-1886
[8]   Overexpression and Interactions of Interleukin-10, Transforming Growth Factor β, and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma [J].
Gholamin, Mehran ;
Moaven, Omeed ;
Memar, Bahram ;
Farshchian, Moein ;
Naseh, Hossein ;
Malekzadeh, Reza ;
Sotoudeh, Masoud ;
Rajabi-Mashhadi, Mohammad Taghi ;
Forghani, Mohammad Naser ;
Farrokhi, Farid ;
Abbaszadegan, Mohammad Reza .
WORLD JOURNAL OF SURGERY, 2009, 33 (07) :1439-1445
[9]   Effective Therapeutic Targeting of the Overexpressed HER-2 Receptor in a Highly Metastatic Orthotopic Model of Esophageal Carcinoma [J].
Gros, Stephanie J. ;
Kurschat, Nina ;
Dohrmann, Thorsten ;
Reichelt, Uta ;
Dancau, Ana-Maria ;
Peldschus, Kersten ;
Adam, Gerhard ;
Hoffman, Robert M. ;
Izbicki, Jakob R. ;
Kaifi, Jussuf T. .
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) :2037-2045
[10]   Improved Survival with Ipilimumab in Patients with Metastatic Melanoma [J].
Hodi, F. Stephen ;
O'Day, Steven J. ;
McDermott, David F. ;
Weber, Robert W. ;
Sosman, Jeffrey A. ;
Haanen, John B. ;
Gonzalez, Rene ;
Robert, Caroline ;
Schadendorf, Dirk ;
Hassel, Jessica C. ;
Akerley, Wallace ;
van den Eertwegh, Alfons J. M. ;
Lutzky, Jose ;
Lorigan, Paul ;
Vaubel, Julia M. ;
Linette, Gerald P. ;
Hogg, David ;
Ottensmeier, Christian H. ;
Lebbe, Celeste ;
Peschel, Christian ;
Quirt, Ian ;
Clark, Joseph I. ;
Wolchok, Jedd D. ;
Weber, Jeffrey S. ;
Tian, Jason ;
Yellin, Michael J. ;
Nichol, Geoffrey M. ;
Hoos, Axel ;
Urba, Walter J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) :711-723